Phase 3 Overweight or Obesity trials recruiting now

All Overweight or Obesity trials, every phase

Other phases for Overweight or Obesity

Phase 3 Overweight or Obesity trials

• A Study of BGM0504 Injection in Participants with Obesity or Overweight
  NCT06704581 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
  NCT07353931 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 152 locations
• Extension Study of the Phase 3 Clinical Study of GZR18 Injection for Weight Loss
  NCT07292441 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations
• Semaglutide for Metabolic Intervention and Adipose Loss to Treat Atrial Fibrillation
  NCT06499857 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.